Apixaban

Whakaahuatanga Poto:

Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP
Apixaban VTE Roto-whare


Taipitopito Hua

Tohu Hua

WHAKAMAHI HUA

Papamuri

Ko te Apixaban he tino whiriwhiri me te aukati i te Factor Xa me nga uara Ki o 0.08 nM me te 0.17 nM i roto i te tangata me te rapeti, ia [1].

Ko te Factor X, e mohiotia ana e te eponym Stuart–Prower factor, he whākōkī o te rourou coagulation.Ka whakahohehia te Tauwehe X, ma te hauwai, ki te tauwehe Xa e te tauwehe IX e rua.Ko te Factor Xa te ahua whakahohe o te coagulation factorthrombokinase.Inhibiting Factor Xa ka taea te tuku i tetahi tikanga rereke mo te anticoagulation.Ko nga aukati Xa Direct he anticoagulants rongonui [2].

In vitro: I whakaatu a Apixabanhas i te kaha o te kaha, te whiriwhiringa, me te whaihua i runga i te Factor Xa me te Ki o 0.08 nM me te 0.17 nM mo te Human Factor Xa me te Rapeti Factor Xa, ia [1].I whakaroahia e Apixaban nga wa o te toto o te plasma tangata noa me nga kukū (EC2x) o 3.6, 0.37, 7.4 me 0.4 μM, e hiahiatia ana kia rua te wa prothrombin (PT), te wa prothrombin whakarereke (mPT), te wa thromboplastin wahanga ( APTT) me te HepTest.I tua atu, i whakaatuhia e Apixaban te kaha teitei o te plasma tangata me te rapeti, engari he iti ake te kaha o te kiore me te plasma kuri i roto i nga whakamatautau PT me te APTT [3].

I roto i te vivo: I whakaatuhia e Apixaban nga rongoa rongoa pai me te iti rawa o te waatea (Cl: 0.02 L kg-1h-1), me te iti o te tohatoha (Vdss: 0.2 L/kg) i roto i te kuri.I tua atu, i whakaatu ano a Apixaban i te haurua o te ora me te T1 / 2 o nga haora 5.8 me te pai o te koiora-waha (F: 58%) [1].I roto i te arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) me te hiko takawaenga carotid arterial thrombosis (ECAT) tauira rapeti, i hangaia e Apixaban nga paanga antithrombotic me te EC50 o 270 nM, 110 nM me te 70 nM i roto i te tikanga o te horopeta [3]. ].I tino whakakorehia e Apixaban te mahi tauwehe Xa me te IC50 o 0.22 μM i roto i te rapeti ex vivo [4].I roto i te chimpanzee, i whakaatu ano a Apixaban i te iti o te tohatoha o te tohatoha (Vdss: 0.17 L kg-1), te iti o te waatea o te punaha (Cl: 0.018 L kg-1h-1), me te pai o te koiora waha (F: 59%) [5].

Tohutoro:
Pinto DJP, Orwat MJ, Koch S, et al.Te kitenga o te 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl)-4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), he tino kaha, he whiriwhiringa, he whai hua, he aukati koiora-a-waha o te tauwehe toto coagulation Xa[J].Journal of medicinal chemistry, 2007, 50(22): 5339-5356.
Sidhu PS. Tikanga Tikanga Xa Inhibitors hei Anticoagulants [J].
Wong PC, Crain EJ, Xin B, et al.Ko te Apixaban, he aukati Xa-waha, tika me te tino whiriwhiri: in vitro, antithrombotic me te antihemostaticstudies[J].Journal of Thrombosis and Haemostasis, 2008, 6 (5): 820-829.
Zhang D, He K, Raghavan N, et al.Metabolism, pharmacokinetics me pharmacodynamics o te tauwehe Xa inhibitor apixaban i roto i te rapeti [J].Journal of thrombosis and thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.pharmacokinetics preclinical me te pharmacodynamics o te apixaban, he kaha me te mea whiriwhiri Xa aukati [J].Te hautaka a te Pakeha mo te tarukino me te rongoa rongoa, 2011, 36 (3): 129-139.

Ko te Apixaban he tino whiriwhiri me te aukati i te Factor Xa me nga uara Ki o 0.08 nM me te 0.17 nM i roto i te tangata me te rapeti, ia [1].

Ko te Factor X, e mohiotia ana e te eponym Stuart–Prower factor, he whākōkī o te rourou coagulation.Ka whakahohehia te Tauwehe X, ma te hauwai, ki te tauwehe Xa e te tauwehe IX e rua.Ko te Factor Xa te ahua whakahohe o te coagulation factorthrombokinase.Inhibiting Factor Xa ka taea te tuku i tetahi tikanga rereke mo te anticoagulation.Ko nga aukati Xa Direct he anticoagulants rongonui [2].

In vitro: I whakaatu a Apixabanhas i te kaha o te kaha, te whiriwhiringa, me te whaihua i runga i te Factor Xa me te Ki o 0.08 nM me te 0.17 nM mo te Human Factor Xa me te Rapeti Factor Xa, ia [1].I whakaroahia e Apixaban nga wa o te toto o te plasma tangata noa me nga kukū (EC2x) o 3.6, 0.37, 7.4 me 0.4 μM, e hiahiatia ana kia rua te wa prothrombin (PT), te wa prothrombin whakarereke (mPT), te wa thromboplastin wahanga ( APTT) me te HepTest.I tua atu, i whakaatuhia e Apixaban te kaha teitei o te plasma tangata me te rapeti, engari he iti ake te kaha o te kiore me te plasma kuri i roto i nga whakamatautau PT me te APTT [3].

I roto i te vivo: I whakaatuhia e Apixaban nga rongoa rongoa pai me te iti rawa o te waatea (Cl: 0.02 L kg-1h-1), me te iti o te tohatoha (Vdss: 0.2 L/kg) i roto i te kuri.I tua atu, i whakaatu ano a Apixaban i te haurua o te ora me te T1 / 2 o nga haora 5.8 me te pai o te koiora-waha (F: 58%) [1].I roto i te arteriovenous-shunt thrombosis (AVST), venous thrombosis (VT) me te hiko takawaenga carotid arterial thrombosis (ECAT) tauira rapeti, i hangaia e Apixaban nga paanga antithrombotic me te EC50 o 270 nM, 110 nM me te 70 nM i roto i te tikanga o te horopeta [3]. ].I tino whakakorehia e Apixaban te mahi tauwehe Xa me te IC50 o 0.22 μM i roto i te rapeti ex vivo [4].I roto i te chimpanzee, i whakaatu ano a Apixaban i te iti o te tohatoha o te tohatoha (Vdss: 0.17 L kg-1), te iti o te waatea o te punaha (Cl: 0.018 L kg-1h-1), me te pai o te koiora waha (F: 59%) [5].

Tohutoro:
Pinto DJP, Orwat MJ, Koch S, et al.Te kitenga o te 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl) phenyl)-4, 5, 6, 7-tetrahydro-1 H-pyrazolo [3, 4- c] pyridine-3-carboxamide (Apixaban, BMS-562247), he tino kaha, he whiriwhiringa, he whai hua, he aukati koiora-a-waha o te tauwehe toto coagulation Xa[J].Journal of medicinal chemistry, 2007, 50(22): 5339-5356.
Sidhu PS. Tikanga Tikanga Xa Inhibitors hei Anticoagulants [J].
Wong PC, Crain EJ, Xin B, et al.Ko te Apixaban, he aukati Xa-waha, tika me te tino whiriwhiri: in vitro, antithrombotic me te antihemostaticstudies[J].Journal of Thrombosis and Haemostasis, 2008, 6 (5): 820-829.
Zhang D, He K, Raghavan N, et al.Metabolism, pharmacokinetics me pharmacodynamics o te tauwehe Xa inhibitor apixaban i roto i te rapeti [J].Journal of thrombosis and thrombolysis, 2010, 29 (1): 70-80.
He K, Luettgen JM, Zhang D, et al.pharmacokinetics preclinical me te pharmacodynamics o te apixaban, he kaha me te mea whiriwhiri Xa aukati [J].Te hautaka a te Pakeha mo te tarukino me te rongoa rongoa, 2011, 36 (3): 129-139.

Hanganga matū

Apixaban

Tiwhikete

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

TE WHAKAMAHI KOI

Quality management1

Tono18Ko nga kaupapa Aromātai Tauritenga Kounga kua whakaaetia4, a6kei te whakamanahia nga kaupapa.

Quality management2

Ko te punaha whakahaere kounga teitei o te ao kua whakatakoto he turanga pakari mo nga hoko.

Quality management3

Ko te tirotiro i te kounga ka haere i roto i te huringa ora katoa o te hua ki te whakarite i te kounga me te hua rongoa.

Quality management4

Ko te roopu Whakahaere Whakahaere Ngaio e tautoko ana i nga hiahia kounga i te wa o te tono me te rehitatanga.

WHAKAMAHI WHAKATANGA

cpf5
cpf6

Korea Countec Pounamu Whakapai Raina

cpf7
cpf8

Taiwan CVC Pounamu Packaging Raina

cpf9
cpf10

Itari CAM Board Packaging Raina

cpf11

Miihini Whakakii Fette Tiamana

cpf12

Hapanihi Viswill Tablet Detector

cpf14-1

Rūma Whakahaere DCS

HOANI

Te mahi tahi o te ao
International cooperation
Te mahi tahi a-whare
Domestic cooperation

  • Tōmua:
  • Panuku:

  • Tuhia to korero ki konei ka tukuna mai ki a matou

    Nga waahanga hua